Related Experiment Video
Updated: Aug 4, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Huntington's Disease-Induced Cardiac Disorders Affect Multiple Cellular Pathways
1Department of Biology, Molecular Biology and Heart Institutes, San Diego State University, San Diego, CA 92182, USA.
Insights
Huntington's disease (HD), a neurological disorder, also significantly impacts heart health, leading to cardiovascular issues like cardiac amyloidosis. Further research is crucial to understand and treat these heart complications in HD patients.
Area of Science:
- Neurology
- Cardiology
- Genetics
Background:
- Huntington's disease (HD) is a rare, inherited neurodegenerative disorder caused by expanded polyglutamine repeats in the huntingtin protein.
- While primarily affecting the central nervous system, heart disease is a leading cause of mortality in HD patients.
- Emerging evidence links HD to cardiovascular diseases, including cardiac amyloidosis.
Purpose of the Study:
- To review and synthesize published literature on pathological factors contributing to HD-induced cardiac amyloidosis and other cardiovascular diseases.
- To identify gaps in current understanding regarding the mechanisms of HD-induced cardiac pathology and its cell autonomy.
- To highlight the need for further comprehensive studies on cardiac function in HD patients.
Main Methods:
- Literature review of experimental animal and clinical studies.
- Analysis of pathological factors such as protein misfolding, autophagic defects, oxidative stress, mitochondrial dysfunction, and cell death.
- Examination of the association between HD and peripheral muscle pathophysiology.
Main Results:
- HD is increasingly recognized as a complex disease with significant peripheral manifestations in cardiac and skeletal muscles.
- Several mechanisms are implicated in HD-induced cardiac pathology, including protein misfolding and mitochondrial dysfunction.
- Despite progress, the precise mechanisms and cell autonomy of HD-induced cardiac pathology remain unclear.
Conclusions:
- HD's impact extends beyond the nervous system to include significant cardiac pathology, particularly cardiac amyloidosis.
- Further investigation into the mechanisms of HD-induced cardiac disease is essential.
- Comprehensive studies are needed to develop therapeutic strategies to mitigate cardiac complications and improve outcomes for HD patients.
Abstract:
Huntington's disease (HD) is a rare, inherited, progressive, and fatal neurological disorder resulting from expanded polyglutamine repeats in the huntingtin protein. While HD is predominately characterized as a disease of the central nervous system, mortality surveys and epidemiological studies reveal heart disease as one of the leading causes of death in HD patients. Emerging evidence supports a link between HD and cardiovascular disease, such as cardiac amyloidosis (accumulation of aggregates in the heart). Experimental animal and clinical studies have attempted to explain the mechanisms of HD-induced cardiac pathology in the association of protein misfolding, autophagic defects, oxidative stress, mitochondrial dysfunction, and cell death. HD is increasingly understood as a complex disease with peripheral components of cardiac and skeletal muscle pathophysiology. While the discovery of these linkages and apparent pathological markers is promising, the mechanism of HD-induced cardiac pathology and the nature of its cell autonomy remain elusive. Further study of the wide-ranging cardiac function in HD patients is needed. This review highlights published literature on the pathological factors associated with HD-induced cardiac amyloidosis and other cardiovascular diseases, and addresses gaps in this expanding area of study. Through comprehensive experimental and clinical studies, potential drugs can be tested to attenuate and/or ameliorate HD-induced cardiac pathology and mortality.
More Related Videos
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Pathophysiology of Heart Failure
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Parkinson Disease ll: Pathophysiology
Huntington Disease l: Introduction